1,278
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Smoking and overweight associated with masked uncontrolled hypertension: a Hypertension Optimal Treatment (HOT) Sub-Study

, , , &
Pages 51-59 | Received 02 Feb 2020, Accepted 20 Jun 2020, Published online: 07 Jul 2020

References

  • HOT Study Group. The Hypertension Optimal Treatment Study (the HOT Study). Blood Press. 1993;2:62–68.
  • Hansson L, Hedner T, Dahlöf B. Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press. 1992;1(2):113–119.
  • Hansson L, Zanchetti A. for HOT Study Group. The Hypertension Optimal Treatment (HOT) Study: patients characteristics – randomization, risk profiles, and early blood pressure results. Blood Press. 1994;3(5):322–327.
  • Hansson L, Zanchetti A, Carruthers SG, et al. for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351(9118):1755–1762.
  • Mejia AD, Julius S, Jones KA, et al. The Tecumseh Blood Pressure Study: normative data on blood pressure self-determination. Arch Intern Med. 1990;150(6):1209–1213.
  • Kjeldsen SE, Moan A, Petrin J, et al. Evaluation of self-measured home vs. clinic intra-arterial blood pressure. Blood Press. 1993;2(1):28–34.
  • Julius S. Home blood pressure monitoring: advantages and limitations. J Hypertens. 1991;9(3):S41–S46.
  • Williams B, Mancia G, Spiering W, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314–340.
  • Kjeldsen SE, Hedner T, Jamerson K, et al. Hypertension Optimal Treatment (HOT) Study: home blood pressure in treated hypertensive subjects. Hypertension. 1998;31(4):1014–1020.
  • Lithell H, Berglund L. Validation of an oscillometric blood pressure measuring device: a substudy of the HOT Study. Hypertension Optimal Treatment. Blood Press. 1998;7(3):149–152.
  • Mancia G, Facchetti R, Cuspidi C, et al. Limited reproducibility of MUCH and WUCH: evidence from the ELSA Study. Eur Heart J. 2020;41(16):1565–1571.
  • Kjeldsen SE, Os I. Poor reproducibility of masked and white coat un-controlled hypertension – important new information on MUCH and WUCH. Eur Heart J. 2020;41(16):1572–1574.
  • Siddiqui M, Judd EK, Dudenbostel T, et al. Masked uncontrolled hypertension is not attributable to medication non-adherence. Hypertension. 2019;74(3):652–659.
  • Kjeldsen SE, Os I. Are people with masked hypertension adherent to their antihypertensive medication? Hypertension. 2019;74(3):497–498.
  • Banegas JR, Ruilope LM, de la Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014;35(46):3304–3312.
  • Kjeldsen SE, Jamerson K, Julius S, et al. Characteristics of reversed office hypertension – may treatment resistant home hypertension be explained by smoking? J Hypertens. 2004;22(2):S138.
  • Vriz O, Nesbitt S, Krause L, et al. Smoking is associated with higher cardiovascular risk in young women than in men: the Tecumseh Blood Pressure Study. J Hypertens. 1997;15(2):127–134.
  • Obara T, Ohkubo T, Funahashi J, et al. Isolated uncontrolled hypertension at home and in the office among treated hypertensive patients from the J-HOME Study. J Hypertens. 2005;23:1653–1660.
  • Makris TK, Thomopoulos C, Papadopoulos DP, et al. Association of passive smoking with masked hypertension in clinically normotensive nonsmokers. Am J Hypertens. 2009;22(8):853–859.
  • Mikkelsen KL, Wiinberg N, Høegholm A, et al. Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects. Am J Hypertens. 1997;10(5):483–491.
  • Narkiewicz K, Maraglino G, Biasion T, et al. Interactive effect of cigarettes and coffee on daytime systolic blood pressure in patients with mild essential hypertension. Hypertension Ambulatory Recording VEnetia STudy (HARVEST) Study Group (Italy). J Hypertens. 1995;13(9):965–970.
  • Bolinder G, de Faire U. Ambulatory 24-h blood pressure monitoring in healthy, middle-aged smokeless tobacco users, smokers, and nontobacco users. Am J Hypertens. 1998;11(10):1153–1163.
  • Groppelli A, Giorgi DM, Omboni S, et al. Persistent blood pressure increase induced by heavy smoking. J Hypertens. 1992;10(5):495–499.
  • Omvik P. How smoking affects blood pressure. Blood Press. 1996;5(2):71–77.
  • Narkiewicz K, Kjeldsen SE, Hedner T. Is smoking a causative factor of hypertension? Blood Press. 2005;14(2):69–71.
  • Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J. 1986;111(5):932–940.
  • Mann SJ, James GD, Wang RS, et al. Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case control study. JAMA 1991;265(17):2226–2228.
  • Mundal R, Kjeldsen SE, Sandvik L, et al. Predictors of 7-year changes in exercise blood pressure; effects of smoking, physical fitness and pulmonary function. J Hypertens. 1997;15(3):245–249.
  • Mundal R, Kjeldsen SE, Sandvik L, et al. Clustering of coronary risk factors with increasing blood pressure at rest and during exercise. J Hypertens. 1998;16:19–22.
  • Alwan H, Pruijm M, Ponte B, et al. Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH Study. PLoS One. 2014;9(3):e92522.
  • Mallion JM, Clerson P, Bobrie G, et al. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens. 2006; 24:2365–2370.
  • Verberk WJ, Thien T, de Leeuw PW. Masked hypertension, a review of the literature. Blood Press Monit. 2007;12(4):267–273.
  • Hwang ES, Choi KJ, Kang DH, et al. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients. Korean J Intern Med. 2007;22(4):256–262.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.